Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy

World Journal of Clinical Oncology
Ozkan Kanat, Hulya Ertas

Abstract

Continuous inhibition of angiogenesis beyond progression is an emerging treatment concept in the management of metastatic colorectal cancer patients with prior bevacizumab exposure. Treatment options include the continuation or reintroduction of bevacizumab during the second-line chemotherapy or switching to a different antiangiogenic monoclonal antibody such as aflibercept or ramucirumab. In the selection of treatment, patient-based factors such as performance status, age, tumor burden, and tolerance and sensitivity to the first-line bevacizumab-based therapy, as well as treatment-related factors such as toxicity, efficacy, and cost, should be taken into consideration.

References

Feb 9, 2006·Cellular and Molecular Life Sciences : CMLS·S Cébe-SuarezK Ballmer-Hofer
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R TonraDaniel J Hicklin
Oct 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyMark Kozloff
Apr 30, 2010·Current Drug Targets·Gang Niu, Xiaoyuan Chen
Oct 13, 2012·Journal of Hematology & Oncology·Weijing Sun
Nov 22, 2012·The Lancet Oncology·Jaafar BennounaUNKNOWN ML18147 Study Investigators
Sep 3, 2013·Journal of Gastrointestinal Oncology·Jeffrey M Clarke, Herbert I Hurwitz
Oct 17, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Clement Chung, Nisha Pherwani
Oct 22, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Josep TaberneroCarmen J Allegra
Nov 2, 2013·Therapeutic Advances in Gastroenterology·Patricia A Tang, Malcom J Moore
Dec 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paul RuffEric Van Cutsem
Jul 21, 2015·World Journal of Gastrointestinal Oncology·Bhavana KondaLakshmi Rajdev
Aug 1, 2015·Critical Reviews in Oncology/hematology·Vincenzo RicciTeresa Fabozzi
Feb 26, 2016·Critical Reviews in Oncology/hematology·Riccardo GiampieriMario Scartozzi
May 31, 2016·Therapeutic Advances in Medical Oncology·Helena VerdaguerTeresa Macarulla
Jun 12, 2016·Pharmacology & Therapeutics·Beverly L FalconBronislaw Pytowski
Jul 7, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemD Arnold
Sep 28, 2016·World Journal of Gastrointestinal Oncology·Yoshihito OhharaHirotoshi Dosaka-Akita
Nov 14, 2016·Cancer Treatment Reviews·Fabio GelsominoStefano Cascinu
Oct 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Sanz-GarciaJ Tabernero
Apr 17, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SienaL Trusolino
Apr 25, 2018·International Journal of Molecular Sciences·Chloe J PeachJeanette Woolard
Nov 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Sanz-GarciaJ Tabernero

❮ Previous
Next ❯

Citations

Jul 25, 2019·The Australasian Journal of Dermatology·Alvaro Martínez-DoménechAmparo Pérez-Ferriols
Jun 12, 2021·Clinical Pharmacology and Therapeutics·Robert B DiasioSteven M Offer

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts

Software Mentioned

BEBYP
RAISE
VELOUR
SPIRITT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.